Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.62 is 157% above its 5-year average of 0.24, near the low end of its 5-year range (0.00–2.31).
As of the fiscal period ended Tuesday, June 30, 2026. 10.05% below its 12-month average of 0.69.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.62.
QUICK RATIO (ACID-TEST)
0.62
QUICK RATIO (ACID-TEST) AVG TTM
0.69
QUICK RATIO (ACID-TEST) AVG 3Y
0.32
QUICK RATIO (ACID-TEST) AVG 5Y
0.24
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.05%
CURRENT VS 3Y AVG
+97.08%
CURRENT VS 5Y AVG
+156.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.32
median of 859 covered companies
CURRENT VS SECTOR MEDIAN
-81.26%
vs the sector median at left
Jupiter Neurosciences, Inc.
Market Cap
$1.45M
Quick Ratio (Acid-Test)
0.62
TTM Avg
0.69
3Y Avg
0.32
5Y Avg
0.24
Market Cap
$1.44M
Quick Ratio (Acid-Test)
0.67
TTM Avg
0.15
3Y Avg
0.14
5Y Avg
1.64
Market Cap
$1.47M
Quick Ratio (Acid-Test)
7.70
TTM Avg
0.13
3Y Avg
0.13
5Y Avg
0.13
Market Cap
$1.47M
Quick Ratio (Acid-Test)
1.30
TTM Avg
2.54
3Y Avg
2.69
5Y Avg
2.23
Market Cap
$1.36M
Quick Ratio (Acid-Test)
3.00
TTM Avg
0.80
3Y Avg
7.12
5Y Avg
9.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.45M | 0.62 | 0.69 | 0.32 | 0.24 |
| INVO Fertility, Inc. (IVF)vs › | $1.44M | 0.67 | 0.15 | 0.14 | 1.64 |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | 0.27 | 1.06 | 2.93 | 2.76 |
| Curis, Inc. (CRIS)vs › | $1.42M | 0.49 | 0.94 | 3.46 | 6.68 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.47M | 7.70 | 0.13 | 0.13 | 0.13 |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 1.30 | 2.54 | 2.69 | 2.23 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 3.00 | 0.80 | 7.12 | 9.62 |
| Genprex, Inc. (GNPX)vs › | $1.34M | 6.77 | 2.33 | 3.65 | 16.80 |
| NewcelX Ltd. (NCEL)vs › | $1.32M | 0.32 | 1.73 | 1.61 | 1.48 |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | 5.36 | 7.82 | 13.02 | 13.86 |
Quick Ratio
0.62
Excludes inventory
Current Ratio
0.66
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.62 |
| 2026-03-31 | 0.48 |
| 2025-12-31 | 0.63 |
| 2025-09-30 | 0.65 |
| 2025-06-30 | 1.07 |
| 2025-03-31 | 1.91 |
| 2024-12-31 | 2.31 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.01 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-06-30 | 0.09 |
| 2022-03-31 | 0.03 |
| 2021-12-31 | 0.08 |
| 2021-09-30 | 0.25 |
| 2021-06-30 | 0.19 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.13 |
| 2020-09-30 | 0.00 |
